Genentech Inc

We track 2 ClinicalTrials.gov studies led by Genentech Inc. The portfolio skews toward Phase 1 (1 trials).

2 clinical trials sponsored by Genentech Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials by Genentech Inc

A Phase Ia/Ib Dose-Escalation and Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Patients With Locally Advanced Or Metastatic ER-Positive, HER2-Negative Breast Cancer Who Have Previously Progressed During or After CDK4/6 Inhibitor Therapy

NCT07214662 · RECRUITING · Phase 1

NAUTIKA1: A Multicenter, Phase II, Neoadjuvant and Adjuvant Study of Multiple Therapies in Biomarker-selected Patients With Resectable Stages IB-III Non-small Cell Lung Cancer

NCT04302025 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Genentech Inc sponsor?

Genentech Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 1, Phase 2.

What conditions does Genentech Inc research?

Genentech Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Genentech Inc recruiting for clinical trials?

Yes, Genentech Inc currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More